# EDGAR Filing Document

**Accession Number:** 0000940603
**File Stem:** 0001213900-25-073247
**Filing Date:** 2025-8
**Character Count:** 9743
**Document Hash:** 7502d8a96f0af9b8869219a58ad9fe27
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-073247.hdr.sgml**: 20250807

**ACCESSION NUMBER**: 0001213900-25-073247

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250807

**DATE AS OF CHANGE**: 20250807

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ACUREN CORP
- **CENTRAL INDEX KEY:** 0002032966
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-BUSINESS SERVICES, NEC [7389]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-94879
- **FILM NUMBER:** 251195872

**BUSINESS ADDRESS:**
- **STREET 1:** 14434 MEDICAL COMPLEX DRIVE
- **STREET 2:** #100
- **CITY:** TOMBALL
- **STATE:** TX
- **ZIP:** 77377
- **BUSINESS PHONE:** 800-218-7450

**MAIL ADDRESS:**
- **STREET 1:** 14434 MEDICAL COMPLEX DRIVE
- **STREET 2:** #100
- **CITY:** TOMBALL
- **STATE:** TX
- **ZIP:** 77377
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** FRANKLIN MARTIN E
- **CENTRAL INDEX KEY:** 0000940603

**ORGANIZATION NAME:**
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**MAIL ADDRESS:**
- **STREET 1:** C/O MARIPOSA CAPITAL, LLC
- **STREET 2:** 5200 BLUE LAGOON DRIVE, SUITE 855
- **CITY:** MIAMI
- **STATE:** FL
- **ZIP:** 33126

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 2)**

**Acuren Corp**

*(Name of Issuer)*

**Common Stock, par value $0.0001 per share**

*(Title of Class of Securities)*

**00510N102**

*(CUSIP Number)*

**Mariposa Acquisition IX, LLC**<br>c/o Mariposa Capital, LLC<br>500 South Pointe Drive, Suite 240<br>Miami Beach FL 33139<br>(786) 482-6333

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**08/07/2025**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **00510N102** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Sir Martin E. Franklin** | Name of reporting person<br>**Sir Martin E. Franklin** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X0** | Citizenship or place of organization<br>**X0** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**19877500.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**19877500.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**19877500.00** | Aggregate amount beneficially owned by each reporting person<br>**19877500.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**9.86%** | Percent of class represented by amount in Row (11)<br>**9.86%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Comment for Reporting Person:** 1. The percentage of Common Stock beneficially owned by the Reporting Person is based on 200,598,758 shares of Common Stock and 1,000,000 shares of Series A Preferred Stock outstanding as of August 6, 2025, following the completion of the transactions contemplated by the Merger Agreement.

| **CUSIP No.** | **00510N102** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Mariposa Acquisition IX, LLC** | Name of reporting person<br>**Mariposa Acquisition IX, LLC** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**19877500.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**19877500.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**19877500.00** | Aggregate amount beneficially owned by each reporting person<br>**19877500.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**9.86%** | Percent of class represented by amount in Row (11)<br>**9.86%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**OO** | Type of Reporting Person (See Instructions)<br>**OO** | |

---

**Comment for Reporting Person:** 2. The percentage of Common Stock beneficially owned by the Reporting Person is based on 200,598,758 shares of Common Stock and 1,000,000 shares of Series A Preferred Stock outstanding as of August 6, 2025, following the completion of the transactions contemplated by the Merger Agreement.

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Stock, par value $0.0001 per share

**(b) Name of Issuer:**
Acuren Corp

**(c) Address of Issuer's Principal Executive Offices:**
14434 Medical Complex Drive, #100, Tomball, TX, 77377

This Amendment No. 2 ("Amendment No. 2") amends and supplements the Schedule 13D, originally filed with the Securities and Exchange Commission on February 14, 2025 and amended on May 16, 2025 (as amended, the "Statement"), relating to the common stock, par value $0.0001 per share (the "Common Stock"), of Acuren Corporation (the "Issuer"), a Delaware corporation. Except as specifically provided herein, this Amendment No. 2 does not modify any of the information previously reported in the Statement. Unless otherwise indicated herein, capitalized terms used but not defined in this Amendment No. 2 shall have the same meanings herein as are ascribed to such terms in the Statement.

**Item 4. Purpose of Transaction**

Item 4 of the Statement is supplemented as follows:

On August 4, 2025, the Issuer completed the transactions contemplated by the Merger Agreement. Solely as a result of the issuance of shares of Common Stock by the Issuer in connection with the transactions contemplated by the Merger Agreement and the resulting increase in the number of shares of Common Stock outstanding, the Reporting Persons' percentage ownership in the Common Stock decreased.  On August 7, 2025, the Issuer notified the Reporting Persons of the number of shares of Common Stock outstanding following the Merger.

Pursuant to the terms of the Voting Agreement, the Voting Agreement automatically terminated upon receipt of the approval of the Acuren Stock Issuance at the Annual Meeting of Stockholders of the Issuer on July 31, 2025.

**Item 5. Interest in Securities of the Issuer**

**(a)**
The information set forth on the cover pages of this Schedule 13D/A is hereby incorporated by reference into this Item 5.

**(b)**
The information set forth on the cover pages of this Schedule 13D/A is hereby incorporated by reference into this Item 5.

**(c)**
The information set forth in Item 4 of this Statement is incorporated by reference herein.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

Item 6 is hereby amended and supplemented by the information set forth above in Item 4 which is incorporated herein by reference.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Sir Martin E. Franklin

**Signature:** /s/ Sir Martin E. Franklin

**Name/Title:** Sir Martin E. Franklin

**Date:** 08/07/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Mariposa Acquisition IX, LLC

**Signature:** /s/ Sir Martin E. Franklin

**Name/Title:** Sir Martin E. Franklin, its Manager

**Date:** 08/07/2025